Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ETRM > SEC Filings for ETRM > Form 8-K on 20-Sep-2016All Recent SEC Filings

Show all filings for ENTEROMEDICS INC

Form 8-K for ENTEROMEDICS INC


20-Sep-2016

Change in Directors or Principal Officers


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) On September 14, 2016, the Board of Directors (the "Board") of EnteroMedics, Inc. (the "Company") approved individual performance objectives and a potential bonus for the Company's President and Chief Executive Officer under the Company's Management Incentive Plan, as amended (the "Plan"), for fiscal year 2016. A summary of the Plan was previously attached as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on February 12, 2008 and is incorporated herein by reference. A summary of the performance objectives under the Plan for the fiscal year ending December 31, 2016, adopted by the Company's Compensation Committee on May 4, 2016, was previously disclosed on the Company's Current Report on Form 8-K filed on May 10, 2016 and is incorporated herein by reference.

In order to further incentivize the successful commercialization of the Company's vBloc Rechargeable System, the Board approved an individual performance objective for the Company's President and Chief Executive Officer consisting of the achievement of certain levels of unit sales of the Company's vBloc Rechargeable System in fiscal year 2016. Depending on the number of units sold, the Company's President and Chief Executive Officer will be eligible to receive an option award in addition to any cash bonus awarded under the Plan for achievement of the "Base Plan" or "Incremental Plan" objectives. If a threshold number of units are sold, the Company's President and Chief Executive Officer would be granted an option to purchase 400,000 to 750,000 shares with the number of shares depending on how many units are sold above the threshold. The option would be granted on January 17, 2017, with an exercise price equal to the fair market value of the stock on that date.

The Board did not revise the "Base Plan" or "Incremental Plan" objectives for participants in the Plan that were previously adopted by the Compensation Committee on May 4, 2016, nor did it amend any of the individual objectives for other participants in the Plan. In addition, the Board did not revise any of the maximum cash bonus percentages adopted by the Compensation Committee on May 4, 2016 with respect to the participants in the Plan.


  Add ETRM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ETRM - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.